Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A BOND

Showing results (631-640 of 682) with videos related to

Pageof 69
Sort By:
Blood Advances|February 24, 2026
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphomaJia Ruan, David A Bond, Bijal Shah, et al.
Plos One|November 26, 2015
Long-Acting Beta Agonists Enhance Allergic Airway DiseaseJohn M Knight, Garbo Mak, Joanne Shaw, et al.
Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.
Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.
Blood Advances|November 25, 2025
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell LymphomaJia Ruan, David A Bond, Bijal D Shah, et al.
Neuron|March 31, 2026
Alzheimer's disease pathology degrades an NMDA receptor-dependent spontaneous activity pattern in cortico-hippocampal circuitsRobert Ellingford, Samuel S Harris, Marten Kehring, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|February 15, 2021
COVID-19 infection in patients with intestinal failure: UK experienceP J Allan, T Ambrose, C Mountford, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Using human genetics to understand the effect of modulating targets of antihypertensive drugs in pregnancyMaria Carolina Borges, Helena Urquijo, Qian Yang, et al.
Science Advances|February 26, 2025
Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variantL Carissa Aurelia, Ruth A Purcell, Robert M Theisen, et al.
Blood|September 22, 2023
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective studyDavid A Qualls, Nicholas Lambert, Paolo F Caimi, et al.
Pageof 69

Showing results (631-640 of 682) with videos related to

Sort By:
Pageof 69
Blood Advances|February 24, 2026
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphomaJia Ruan, David A Bond, Bijal Shah, et al.
Plos One|November 26, 2015
Long-Acting Beta Agonists Enhance Allergic Airway DiseaseJohn M Knight, Garbo Mak, Joanne Shaw, et al.
Vaccine|June 17, 2025
Genetic markers of enhanced functional antibody responses to COVID-19 vaccinationRuth A Purcell, L Carissa Aurelia, Lilith F Allen, et al.
Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.
Blood Advances|November 25, 2025
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell LymphomaJia Ruan, David A Bond, Bijal D Shah, et al.
Neuron|March 31, 2026
Alzheimer's disease pathology degrades an NMDA receptor-dependent spontaneous activity pattern in cortico-hippocampal circuitsRobert Ellingford, Samuel S Harris, Marten Kehring, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|February 15, 2021
COVID-19 infection in patients with intestinal failure: UK experienceP J Allan, T Ambrose, C Mountford, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Using human genetics to understand the effect of modulating targets of antihypertensive drugs in pregnancyMaria Carolina Borges, Helena Urquijo, Qian Yang, et al.
Science Advances|February 26, 2025
Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variantL Carissa Aurelia, Ruth A Purcell, Robert M Theisen, et al.
Blood|September 22, 2023
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective studyDavid A Qualls, Nicholas Lambert, Paolo F Caimi, et al.
Pageof 69